PMA device
Vivistim® Paired VNS System
Mobia Medical, Inc. · Stimulator, Autonomic Nerve, Implanted For Stroke Rehabilitation (QPY, Class III) · First FDA decision Feb 26, 2026, newest Feb 26, 2026Stroke recovery and rehabilitation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
6
Naming "Vivistim Paired VNS"
MAUDE reports
0
Brand "Vivistim Paired VNS", since 2015
PubMed studies
0
Mentioning "Vivistim Paired VNS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Vivistim® Paired VNS System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Vivistim® Paired VNS SystemPMA supplement
P210007-S008 · Decided Feb 26, 2026 · 92 days after receipt · Normal 180 Day Track
Device type: Stimulator, autonomic nerve, implanted for stroke rehabilitation (QPY) · Physical Medicine & Rehabilitation
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Phrenic Nerve StimulatorNational determinationOn the books160.19Updated Jun 12, 2020
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Vivistim Paired VNS", any status and sponsor, newest update first.
MicroTransponder Inc.Not on our public-company list
NCT05301140 · 1,000 participants (planned) · Start Mar 15, 2023 · Primary completion Dec 31, 2028
Device: Vivistim System · For: Upper Extremity Problem
Sites: Orlando, Florida; Elk Grove Village, Illinois; Evanston, Illinois · 16 sites in all
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Vivistim Paired VNS", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QPY
74 reports: 4 malfunction, 70 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Vivistim Paired VNS"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QPY.
- Vivistim SystemMobia Medical, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.